Glenmede Trust’s Precigen PGEN Stock Holding History

Glenmede Trust’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,000	Closed	-$10K	–	1957
2020 Q3	$10K	Buy	+3,000	New	+$14.2K	﹤0.01%	1886
2017 Q3	–	Sell	-300	Closed	-$5K	–	2806
2017 Q2	$5K	Hold	300	–	–	﹤0.01%	2291
2017 Q1	$5K	Sell	300 -3	-1%	-$67	﹤0.01%	2291
2016 Q4	$7K	Hold	303	–	–	﹤0.01%	2176
2016 Q3	$8K	Hold	303	–	–	﹤0.01%	2182
2016 Q2	$7K	Hold	303	–	–	﹤0.01%	2179
2016 Q1	$10K	Buy	+303	New	+$9.54K	﹤0.01%	2048

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Glenmede Trust's PGEN Position: Q4 2020 in Review

Glenmede Trust sold out of Precigen (PGEN) in Q4 2020, closing a stake of 3,000 shares — an estimated $10K sold.

Glenmede Trust first reported a position in PGEN in Q1 2016 and held it in 7 quarters. The position peaked at $10K in Q3 2020. 151 funds tracked by Wall St. Rank hold PGEN as of Q4 2020.

Glenmede Trust reported no remaining Precigen position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 3,000 Precigen shares in Q4 2020, an estimated $10K.
Glenmede Trust first reported a position in Precigen in Q1 2016 and held it in 7 quarters.
Glenmede Trust's Precigen position peaked at $10K in Q3 2020.
151 funds tracked by Wall St. Rank held Precigen as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.